Loading viewer...
earnings
Format: PDF earnings
Lenzing AG presents full year 2015 results with strong operational performance including 6.0% revenue growth to EUR 1,977 million and 20.7% EBITDA growth to EUR 290.1 million. The presentation highlights strategic portfolio realignment through asset sales and introduces the new Score TEN strategy focused on value growth, with a proposed dividend increase to EUR 2.00 per share.
earnings
61 Pages
earnings
21 Pages
Vertex Pharmaceuticals